Elon Musk and his startup Neuralink’s scientists showed off a new brain-computer interface they say will advance therapeutic devices treating various neurological conditions with a new level of precision. The technology, in development for two years, will soon be submitted to the U.S. Food and Drug Administration for testing on human subjects. The company thus far has received $158 million in funding and has about 100 employees. Musk stated that one goal of the announcement is to recruit more talent. Continue reading Elon Musk’s Neuralink Showcases Brain-Computer Interface